Stangherlin, A
If you're a pharmaceutical company and you see that there's 15 to 20 other peptides which are really working and really working, because again, we've just seen the clinical response over and over and over, it's not a large leap to think, "Hey, if we're a pharmaceutical company, what if we turn that peptide, which was available to the commoner, for lack of a better term, into a drug?" Andrew: Oh, like Vyleesi
GLP-1 is a hormone that helps regulate blood sugar levels by stimulating insulin release and reducing the amount of glucose produced by the liver
doi: 10.1016/j.psychres.2013.08.035 18 MaJYanLGuoTYangSNiDLiuYet al
Available at: Jung SY et al (2011): Short-acting nifedipine and risk of stroke in elderly hypertensive patients
However, in evolutionary context it makes sense, as Met-derived GSLs are a later invention in plant evolution (both in comparison to other types of GSL and other types of secondary metabolites), and during evolution plants made use of already existing transporters from primary metabolism
